The patients, who ranged in age from 23 to 66, were diagnosed with acutelymphoblasticleukemia, or ALL, and had previously relapsed after standard chemotherapy.
In another path-breaking example, consider the case of Dr. Lucas Wartman, a young physician who developed adult acutelymphoblasticleukemia, a disease that is usually rapidly fatal, and for which there is no effective treatment.